DNLI NASDAQ
Denali Therapeutics Inc.
1W: -0.5%
1M: -4.7%
3M: -4.4%
YTD: +18.6%
1Y: +35.1%
3Y: -34.1%
5Y: -64.2%
$18.64
-0.66 (-3.42%)
Weekly Expected Move ±7.0%
$16
$17
$19
$20
$21
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026298
Institutions Holding
+11 vs prior
76.6%
Ownership
-1.20%
49
New
89
Increased
115
Reduced
63
Closed
👔 Insider Trades
23 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-06 | Watts Ryan J. | officer: president and ceo | S-Sale | 35,198 | $16.50 | $581K | Filing |
| 2026-01-06 | Schuth Alexander O. | officer: cofo and secretary | S-Sale | 17,218 | $16.50 | $284K | Filing |
| 2026-01-03 | Watts Ryan J. | officer: president and ceo | A-Grant/Award | 78,960 | $— | $0 | Filing |
| 2026-01-03 | Schuth Alexander O. | officer: cofo and secretary | A-Grant/Award | 57,700 | $— | $0 | Filing |
| 2025-11-04 | Van Hauwermeiren Timothy | director | A-Grant/Award | 10,632 | $— | $0 | Filing |
| 2025-09-03 | Watts Ryan J. | officer: president and ceo | G-Gift | 50,000 | $— | $0 | Filing |
| 2025-08-13 | Ho Carole | officer: chief medical officer | S-Sale | 806 | $14.64 | $12K | Filing |
| 2025-08-12 | Ho Carole | officer: chief medical officer | S-Sale | 2,937 | $13.58 | $40K | Filing |
| 2025-08-12 | Schuth Alexander O. | officer: cofo and secretary | S-Sale | 2,937 | $13.58 | $40K | Filing |
| 2025-07-09 | Watts Ryan J. | officer: president and ceo | S-Sale | 495,282 | $15.00 | $7.4M | Filing |
| 2025-06-03 | BAKER BROS. ADVISORS LP | director | A-Grant/Award | 10,565 | $— | $0 | Filing |
| 2025-06-03 | 667, L.P. | director | A-Grant/Award | 10,565 | $— | $0 | Filing |
| 2025-06-03 | Baker Bros. Advisors (GP) LLC | director | A-Grant/Award | 10,565 | $— | $0 | Filing |
| 2025-06-03 | Baker Brothers Life Sciences LP | director | A-Grant/Award | 10,565 | $— | $0 | Filing |
| 2025-06-03 | BAKER FELIX | director | A-Grant/Award | 10,565 | $— | $0 | Filing |
| 2025-06-03 | BAKER JULIAN | director | A-Grant/Award | 10,565 | $— | $0 | Filing |
| 2025-06-03 | Cook Jennifer E. | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
| 2025-06-03 | Tessier-Lavigne Marc | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
| 2025-06-03 | Thornberry Nancy | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
| 2025-06-03 | Schenkein David P | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
| 2025-06-03 | Krognes Steve E. | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
| 2025-06-03 | Klein Peter S | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
| 2025-06-03 | FLATLEY JAY T | director | A-Grant/Award | 6,037 | $— | $0 | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,034,434 | $250M | +319,233 | 2026-03-31 | Filing |
| BAILLIE GIFFORD & CO | 12,066,479 | $232M | -244,410 | 2026-03-31 | Filing |
| Temasek Holdings (Private) Ltd | 7,012,974 | $135M | — | 2026-03-31 | Filing |
| STATE STREET CORP | 6,272,001 | $120M | +8,630 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 6,147,957 | $118M | +6,147,957 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,120,160 | $118M | +6,120,160 | 2026-03-31 | Filing |
| FMR LLC | 4,575,374 | $88M | -1,521,837 | 2026-03-31 | Filing |
| UBS AM, a distinct business unit of UBS | 4,432,314 | $85M | -551,412 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 4,407,255 | $85M | +571,452 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 3,727,114 | $72M | +268,983 | 2026-03-31 | Filing |
| Holocene Advisors, LP | 3,195,429 | $61M | +42,695 | 2026-03-31 | Filing |
| DIMENSIONAL FUND ADVISORS LP | 2,692,175 | $52M | +317,872 | 2026-03-31 | Filing |
| UBS Group AG | 2,571,344 | $49M | +166,640 | 2026-03-31 | Filing |
| Pictet Asset Management Holding SA | 2,558,865 | $48M | +1,229,757 | 2026-03-31 | Filing |
| Capital Research Global Investors | 2,514,588 | $48M | -1,214,656 | 2026-03-31 | Filing |
| Fisher Asset Management, LLC | 2,436,895 | $47M | -152,508 | 2026-03-31 | Filing |
| Crestline Management, L.P. | 2,210,732 | $42M | -600,000 | 2026-03-31 | Filing |
| Lynx1 Capital Management LP | 1,880,303 | $36M | +141,553 | 2026-03-31 | Filing |
| ADAR1 Capital Management, LLC | 1,871,455 | $36M | +1,819,339 | 2026-03-31 | Filing |
| Aberdeen Group plc | 1,854,446 | $36M | -178,521 | 2026-03-31 | Filing |